Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Menu
My View
  • Edit
  • Add your favourite topics for quick access
Meet the Team
Ask the Analyst
Partnered Content
PDF Library
RSS Feeds
Subscribe
Advertising
Report Store
UsernamePublicRestriction
Tags:
BioPharmaceutical

Who's Liable For Online Content? Pharma, Marketers Disagree (Slightly)

  • News

Executive Summary

Compensation and collaboration - as well as creation - should be the triggers for determining a pharmaceutical company's liability for Internet content, Rohit Bhargava of Ogilvy 360 Digital Influence advised FDA during a Nov. 12-13 hearing on promoting medical products on the Internet and in social media
Table

View full table

Advertisement

Related Content

Pink Sheet
FDA’s Twitter Formula Allows Tweets About Products Without Excessive Risks
Pink Sheet
Pharma Social Media Sites Struggle For Audience Under Shadow Of Potential FDA Action
Pink Sheet
Internet-Focused Promotion, Warning Letters Both Up As FDA Guidance Nears
Pink Sheet
Internet-Focused Promotion, Warning Letters Both Up As FDA Guidance Nears
Pink Sheet
FDA's Internet Promotion Policy: Christmas Cards In Lieu Of Guidance?
Pink Sheet
Get Moving On Social Media, But Carefully, Attorneys And Marketers Say
Pink Sheet
Tysabri Webcast Citation May Signal That FDA Could Treat All Social Media Interactions As Promotional; Biogen's PML Strategy Also Takes A Hit
Pink Sheet
Interactive Web Sites Hold High Risk For Marketing Non-Compliance
Pink Sheet
Interactive Web Sites Hold High Risk For Marketing Non-Compliance
Pink Sheet
DDMAC 2.0: FDA To Host November Meeting On Web And New Media Promotion

Topics

Advertisement
Tags:
BioPharmaceutical
UsernamePublicRestriction

Register

PS051722

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By